Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.
Fiche publication
Date publication
décembre 2015
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
Tous les auteurs :
Brasseur M, Heurgué-Berlot A, Barbe C, Brami C, Rey JB, Vella-Boucaud J, Dabouz F, Deslée G, Grange F, Volet J, Bouché O
Lien Pubmed
Résumé
Reactivation of hepatitis B or C virus can occur in patients undergoing chemotherapy. Recommendations for selective or systematic hepatitis B virus testing prior chemotherapy for solid tumors differ. The primary aim was to determine the seroprevalence of hepatitis B or C in a low endemic country. The second objective was to assess the relevance of a questionnaire on hepatitis B/C risk factors to consider a selective screening.
Mots clés
Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, France, epidemiology, Hepatitis B, diagnosis, Hepatitis C, diagnosis, Humans, Male, Middle Aged, Neoplasms, drug therapy, Prevalence, Prospective Studies, Risk Factors, Seroepidemiologic Studies, Surveys and Questionnaires, Young Adult
Référence
BMC Cancer. 2015 Dec;15:999